Masaki Kawamura

2PUBLICATIONS
8CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Traditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Feb 25, 2021
Efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 64-week phase 3 study (reSURFACE 1).

Atsuyuki Igarashi, Hidemi Nakagawa, Akimichi Morita

|Feb 01, 2021
Long-term efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 5-year extension of a phase 3 study (reSURFACE 1).

Shinichi Imafuku, Hidemi Nakagawa, Atsuyuki Igarashi

Pageof 1

Frequent Collaborators

2 joint publications

Shinichi Imafuku

2 joint publications

Hidemi Nakagawa

2 joint publications

Atsuyuki Igarashi

2 joint publications

Akimichi Morita